44. Мартинюк В.Ю., Кисіль Т.М., Радзинко Л.В. Аналіз причин первинної інвалідності дітей, пов'язаних з захворюванням на церебральний параліч за 2004 рік та у порівнянні з 1995, 1998 і 2001 роками: Соціальна педіатрія. Вип. III // Збірник наукових праць. - К: Інтермед, 2005. - С. 30 - 31.
45. Мартинюк В.Ю., Краснов В.В., Назар О.В., Мельничук В.Я. До питання про постмаркетингову оцінку ефективності медикаментозних препаратів в лікуванні захворювань нервової системи у дітей: Соціальна педіатрія. Вип. III // Збірник наукових праць. - К: Інтермед, 2005. - С. 203 - 207.
46. Мартинюк В.Ю. Протоколи лікування епілепсії, епілептичних синдромів та епілептичного статусу у дітей: Соціальна педіатрія. Вип. III // Збірник наукових праць. - К.: Інтермед, 2005. - С. 364 - 372.
47. Моісеєнко Р.О., Педан В.Б., Бережний В.В., Гойда Н.Г., Мартинюк В.Ю., Зінченко С.М., Шевцов А.Г. Організаційно-методичні основи медико-соціальної реабілітації дітей з обмеженими можливостями здоров'я // Современная педиатрия. - 2005. - N 3 (8). - С. 23 - 27.
48. Яковлева Л.П., Мартинюк В.Ю., Майструк О.А., Омельянчик С.Й. Бобат-концепція в методологічному означенні неврології // Современная педиатрия. - 2005. - N 3 (8). - с. 182 - 184.
49. Мартынюк В.Ю. К вопросу об эффективности медикаментозной терапии перинатальных поражений нервной системы у детей в раннем восстановительном периоде // Матеріали науково-практичної школи-семінару "Сучасні принципи інтенсивної терапії та виходжування новонароджених" - Судак, АР Крим, 15 - 16 вересня 2005. - С. 29 - 34.
50. Мартинюк В.Ю., Зінченко С.М., Майструк О.А., Козачук В.Г. Модель "Тандем - партнерство, "дитина - сім'я - фахівець" в комплексній реабілітації дітей з обмеженими можливостями здоров'я: Соціальна педіатрія. Вип. III // Збірник наукових праць. - К: Інтермед, 2005. - С. 207 - 209.
51. Мартинюк В.Ю., Майструк О.А. Досвід роботи за моделлю реабілітації "Тандем" Українського медичного центру реабілітації дітей з органічним ураженням нервової системи МОЗ України: Збірник наукових праць співробітників КМАПО ім. П.Л. Шупика. - Київ, 2005. - С. 273 - 276.
52. Мартинюк В.Ю., Л.П. Яковлева, С.Й. Омельянчик Intraduction of Bobath-conception in Ukrainian medical rehabilitation centre for children with organic injuring of nerves system Mynistry of Health of Ukraine. // Abstracts 6th International Congress on Cerebral Palsy "New Advanced in Treatment of Cerebral Palsy". 20 - 22 April, 2006, Bled, Slovenia, p. 21. (p. 13).
53. Лечение заболеваний нервной системы у детей / Под редакцией В.П. Зыкова: Клиническое руководство для врачей, издание 3-е, переработанное, дополненное. - М., 2009. - 416 с. Глава 12. Кинезтотерапия и методики социальной реабилитации. - Мартынюк В.Ю., Здвижкова В.Н., Тараканова Е.Э., Яковлева Л.П. - С. 349 - 360.
54. Козявкін В.І. Метод Козявкіна - система інтенсивної нейрофізіологічної реабілітації. Посібник реабілітолога / Козявкін В.І., Бабадагли М.О., Лунь Г.П., Качмар О.О., Гордієвич С.М. та ін. / Міжнародна клініка відновного лікування, 2011.
55. Козявкін В.І., Качмар О.О. Методи оцінки ефективності в системі інтенсивної нейрофізіологічної реабілітації // Український медичний часопис. - № 3 (35). - 2003. - С. 61 - 66.
56. Козявкін В.І., Качмар О.О. Методи оцінки ефективності в системі інтенсивної нейрофізіологічної реабілітації // Український медичний часопис. - № 3 (35). - 2003. - С. 61 - 66.
57. Козявкін В.І. Оцінка змін моторних функцій у пацієнтів з церебральними паралічами при застосуванні системи інтенсивної нейрофізіологічної реабілітації / Козявкін В.І., Т.Е. Волошин та інші // Соціальна педіатрія та реабілітологія. - № 1. - 2012. - С. 57 - 61.
58. Качмар О.О. Система класифікації великих моторних функцій у дітей із церебральними паралічами // Міжнародний неврологічний журнал. - 2008. - № 1 (17). - С. 90 - 93.
59. Ment LR, Bada HS, Barnes P, et al. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002; 58: 1726 - 1738.
60. Wiklund LM, Uvebrant P, Flodmark O. Computed tomography as an adjunct in etiological analysis of hemiplegic cerebral palsy. II: children born at term. Neuropediatrics. 1991; 22: 121 - 128.
61. Wiklund LM, Uvebrant P, Flodmark O. Computed tomography as an adjunct in etiological analysis of hemiplegic cerebral palsy. I: Children born preterm. Neuropediatrics. 1991; 22: 50 - 56.
62. Miller G, Cala LA. Ataxic cerebral palsy-clinico-radiologic correlations. Neuropediatrics. 1989; 20: 84 - 89.
63. Chen YH. Correlations between computerized tomography of the head and motor developmental disturbances of children with cerebral palsy. J Jpn Orthop. 1981; 55: 85 - 99.
64. Kolawole TM, Patel PJ, Mahdi AH. Computed tomographic (CT) scans in cerebral palsy. Pediatr Radiol. 1989; 20: 23 - 27.
65. Taudorf K, Melchior JC, Pedersen H. CT findings in spastic cerebral palsy. Clinical, aetiological and prognostic aspects. Neuropediatrics. 1984; 15: 120 - 124.
66. Schouman-Claeys E, Picard A, Lalande G, et al. Contribution of computed tomography in the aetiology and prognosis of cerebral palsy in children. Br J Radiol. 1989; 62: 248 - 252.
67. Cohen ME, Duffner PK. Prognostic indicators in hemiparetic cerebral palsy. Ann Neurol. 1981; 9: 353 - 357.
68. Molteni B, Oleari G, Fedrizzi E, et al. Relation between CT patterns, clinical findings and etiological factors in children born at term, affected by congenital hemiparesis. Neuropediatrics. 1987; 18: 75 - 80.
69. Krageloh-Mann I, Petersen D, Hagberg G, et al. Bilateral spastic cerebral palsy - MRI pathology and origin. Analysis from a representative series of 56 cases. Dev Med Child Neurol. 1995; 37: 379 - 397.
70. Yin R, Reddihough D, Ditchfield M, et al. Magnetic resonance imaging findings in cerebral palsy. J Paediatr Child Health. 2000; 36: 139 - 144.
71. Candy EJ, Hoon AH, Capute AJ, et al. MRI in motor delay: important adjunct to classification of cerebral palsy. Pediatr Neurol. 1993; 9: 421 - 429.
72. Okumura A, Kato T, Kuno K, et al. MRI findings in patients with spastic cerebral palsy. II: Correlation with type of cerebral palsy. Dev Med Child Neurol. 1997; 39: 369 - 372.
73. Cioni G, Sales B, Paolicelli PB, et al. MRI and clinical characteristics of children with hemiplegic cerebral palsy. Neuropediatrics. 1999; 30: 249 - 255.
74. Jaw TS, Jong YJ, Sheu RS, et al. Etiology, timing of insult, and neuropathology of cerebral palsy evaluated with magnetic resonance imaging. J Formos Med Assoc. 1998; 97: 239 - 246.
75. Sugimoto T, Woo M, Nishida N, et al. When do brain abnormalities in cerebral palsy occur? An MRI study. Dev Med Child Neurol. 1995; 37: 285 - 292.
76. Hayakawa K, Kanda T, Hashimoto K, et al. MR imaging of spastic diplegia. The importance of corpus callosum. Acta Radiol. 1996; 37: 830 - 836.
77. Truwit CL, Barkovich AJ, Koch TK, et al. Cerebral palsy: MR findings in 40 patients. AJNR Am JNeuroradiol. 1992; 13: 67 - 78.
78. Yokochi K, Aiba K, Kodama M, et al. Magnetic resonance imaging in athetotic cerebral palsied children. Acta Paediatr Scand. 1991; 80: 818 - 823.
79. Haworth JC, Booth FA, Chudley AE, et al. Phenotypic variability in glutaric aciduria type I: report of fourteen cases in five Canadian Indian kindreds. J Pediatr. 1991; 118: 52 - 58.
80. Kyllerman M, Skjeldal OH, Lundberg M, et al. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord. 1994; 9: 22 - 30.
81. Hauser SE, Peters H. Glutaric aciduria type 1: an underdiagnosed cause of encephalopathy and dystonia-dyskinesia syndrome in children. J Paediatr Child Health. 1998; 34: 302 - 304.
82. Baric I, Zschocke J, Christensen E, et al. Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis. 1998; 21: 326 - 340.
83. Smith WE, Millington DS, Koeberl DD, et al. Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics. 2001; 107: 1184 - 1187.
84. Hartley LM, Mrcp B, Khwaja OS, et al. Glutaric aciduria type 1 and nonaccidental head injury. Pediatrics. 2001; 107: 174 - 175.
85. Mitchell G, Mclnnes RR. Differential diagnosis of cerebral palsy: Lesch-Nyhan syndrome without self-mutilation. Can Med Assoc J. 1984; 130: 1323 - 1324.
86. Straussberg R, Brand N, Gadoth N. 3-Methyl glutaconic aciduria in Iraqi Jewish children may be misdiagnosed as cerebral palsy. Neuropediatrics. 1998; 29: 54 - 56.
87. Lissens W, Vreken P, Barth PG, et al. Cerebral palsy and pyruvate dehydrogenase deficiency: identification of two new mutations in the Elalpha gene. Eur J Pediatr. 1999; 158: 853 - 857.
88. Prasad AN, Breen JC, Ampola MG, et al. Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review. J Child Neurol. 1997; 12: 301 - 309.
89. Willis TA, Davidson J, Gray RG, et al. Cytochrome oxidase deficiency presenting as birth asphyxia. Dev Med Child Neurol. 2000; 42: 414 - 417.
90. Gibson KM, Christensen E, Jakobs C, et al. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics. 1997; 99: 567 - 574.
91. Christodoulou J, Qureshi IA, McInnes RR, et al. Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr. 1993; 122: 423 - 425.
92. Lynch JK, Nelson KB, Curry CJ, et al. Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol. 2001; 16: 735 - 744.
93. Gunther G, Junker R, Strater R, et al. Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke. 2000; 31: 2437 - 2441.
94. Mercuri E, Cowan F, Gupte G, et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics. 2001; 107: 1400 - 1404.
95. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 31: 1283 - 1288.
96. Golomb MR, MacGregor DL, Domi T, et al. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol. 2001; 50: 163 - 168.
97. Harum KH, Hoon AH, Jr., Kato GJ, et al. Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy. Dev Med Child Neurol. 1999; 41: 777 - 780.
98. Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol. 1999; 30: 759 - 769.
99. Okun MS, Jummani RR, Carney PR. Antiphospholipid-associated recurrent chorea and ballism in a child with cerebral palsy. Neurology. 2000; 23: 62 - 63.
100. Thorarensen O, Ryan S, Hunter J, et al. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol. 1997; 42: 372 - 375.
101. Wallace SJ. Epilepsy in cerebral palsy. Dev Med Child Neurol. 2001; 43: 713 - 717.
102. Murphy CC, Yeargin-Allsopp M, Decoufle P, et al. Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. J Pediatr. 1993; 123: S13 - S20.
103. von Wendt L, Rantakallio P, Saukkonen AL, et al. Cerebral palsy and additional handicaps in a 1-year birth cohort from northern Finland - a prospective follow-up study to the age of 14 years. Ann Clin Res. 1985; 17: 156 - 161.
104. Zafeiriou DI, Kontopoulos EE, Tsikoulas I. Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol. 1999; 14: 289 - 294.
105. Hadjipanayis A, Hadjichristodoulou C, Youroukos S. Epilepsy in patients with cerebral palsy. Dev Med Child Neurol. 1997; 39: 659 - 663.
106. Al-Sulaiman A. Electroencephalographic findings in children with cerebral palsy: a study of 151 patients. Funct Neurol. 2001; 16: 325 - 328.
107. Chambers HG, Weinstein CH, Mubarak SJ, et al. The effect of valproic acid on blood loss in patients with cerebral palsy. J Pediatr Orthop. 1999; 19: 792 - 795.
108. Bruck I, Antoniuk SA, Spessatto A, et al. Epilepsy in children with cerebral palsy. Arq Neuropsiquiatr. 2001; 59: 35 - 39.
109. Kwong KL, Wong SN, So KT. Epilepsy in children with cerebral palsy. Pediatr Neurol. 1998; 19: 31 - 36.
110. Kaushik A, Agarwal RP, Sadhna. Association of cerebral palsy with epilepsy. J Ind Med Assoc. 1997; 95: 552 - 554, 565.
111. Senbil N, Sonel B, Aydin OF, et al. Epileptic and non-epileptic cerebral palsy: EEG and cranial imaging findings. Brain Dev. 2002; 24: 166 - 169.
112. Fennell EB, Dikel TN. Cognitive and neuropsychological functioning in children with cerebral palsy. J Child Neurol. 2001; 16: 58 - 63.
113. Aram DM, Eisele JA. Limits to a left hemisphere explanation for specific language impairment. J Speech Hear Res. 1994; 37: 824 - 830.
114. Trauner DA, Ballantyne A, Friedland S, et al. Disorders of affective and linguistic prosody in children after early unilateral brain damage. Ann Neurol. 1996; 39: 361 - 367.
115. Schenk-Rootlieb AJ, van Nieuwenhuizen O, van der Graaf Y, et al. The prevalence of cerebral visual disturbance in children with cerebral palsy. Dev Med Child Neurol. 1992; 34: 473 - 480.
116. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine, Section on Ophthalmology. Eye examination and vision screening in infants, children, and young adults. Pediatrics. 1996; 98: 153 - 157.
117. Hartmann EE, Dobson V, Hainline L, et al. Preschool vision screening: summary of a Task Force report on behalf of the Maternal and Child Health Bureau and the National Eye Institute Task Force on Vision Screening in the Preschool Child. Pediatrics. 2000; 106: 1105 - 1116.
118. Clarke WM, Hoops HR. Predictive measures of speech proficiency in cerebral palsied speakers. J Commun Disord. 1980; 13: 385 - 394.
119. Love RJ, Hagerman EL, Taimi EG. Speech performance, dysphagia and oral reflexes in cerebral palsy. J Speech Hear Disord. 1980; 45: 59 - 75.
120. Uvebrant P, Carlsson G. Speech in children with cerebral palsy. Acta Paediatr. 1994; 83: 779.
121. Falkman KW, Sandberg AD, Hjelmquist E. Preferred communication modes: prelinguistic and linguistic communication in non-speaking preschool children with cerebral palsy. Int J Lang Commun Disord. 2002; 37: 59 - 68.
122. Reilly S, Skuse D, Poblete X. Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey. J Pediatr. 1996; 129: 877 - 882.
123. Sullivan PB, Lambert B, Rose M, et al. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol. 2000; 42: 674 - 680.
124. Waterman ET, Koltai PJ, Downey JC, et al. Swallowing disorders in a population of children with cerebral palsy. Int J Pediatr Otorhinolaryngol. 1992; 24: 63 - 71.
125. Blasco PA, Allaire JH, participants of the Consortium on Drooling. Drooling in the developmentally disabled: management practices and recommendations. Dev Med Child Neurol. 1992; 34: 849 - 862.
126. Stallings VA, Charney EB, Davies JC, et al. Nutrition-related growth failure of children with quadriplegic cerebral palsy. Dev Med Child Neurol. 1993; 35: 126 - 138.
127. Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med. 1996; 150: 932 - 935.
128. Pope JE, Curzon ME. The dental status of cerebral palsied children. Pediatr Dentistry. 1991; 13: 156 - 162.
129. Shaw BNJ. The respiratory consequences of neurological deficit. In: Sullivan PB, Rosenbloom L, eds. Feeding the disabled child. Clinics in developmental medicine no. 140. New York: Cambridge University Press, 1996; 40 - 46.
130. Van Naarden K, Decoufle P, Caldwell K. Prevalence and characteristics of children with serious hearing impairment in metropolitan Atlanta, 1991 - 1993. Pediatrics. 1999; 103: 570 - 575.
131. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2000; 106: 798 - 817.
132. Yeargin-Allsopp M, Van Naarden Braun K, Doernberg BA, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics 2008; 121: 547 - 554.
133. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 2006; 33: 251 - 267.
134. Boyle CA, Yeargin-Allsopp M, Doemberg NS, Holmgreen P, Murphy CC, Schendel DE. Prevalence of selected developmental disabilities in children 3 - 10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991. MMWR CDC Surveill Summ 1996; 45: 1 - 14.
135. Ronan S, Gold JT. Nonoperative management of spasticity in children. Childs Nerv Syst 2007; 23: 943 - 956.
136. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003; 111 : e89 - e97.
137. Damiano DL, Quinlivan J, Owen BF, Shaffrey M, Abel MF. Spasticity versus strength in cerebral palsy: relationships among involuntary resistance, voluntary torque, and motor function. Eur JNeurol 2001; 8 suppl 5: 40 - 49.
138. Milla PJ, Jackson AD. A controlled trial of baclofen in children with cerebral palsy. J Int Med Res 1977; 5: 398 - 404.
139. Ward A. Long-term modification of spasticity. J Rehabil Med 2003; 35: 60 - 65.
140. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192 : 540 - 542.
141. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206 - 207.
142. Nielsen JF, Sinkjaer T. A comparison of clinical and laboratory measures of spasticity. Mult Scler 1996; 1: 296 - 301.
143. Haugh AB, Pandyan AD, Johnson GR. A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil 2006; 28: 899 - 907.
144. Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P. Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol 2006; 34: 1 - 6.
145. Gracies JM, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity: part I: local treatments. Muscle Nerve 1997; 6 (suppl): S61 - S91.
146. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity: part II: general and regional treatments. Muscle Nerve 1997; 6 (suppl): S92 - S120.
147. Cony IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997; 39: 185 - 193.
148. Fehlings D, Rang M, Glazier J, Steele C An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 2000; 137: 331 - 337.
149. Lowe K, Novak I, Cusick A. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2006; 48: 170 - 175.
150. Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial. Arch Phys Med Rehabil 2007; 88: 1 - 10.
151. Kawamura A, Campbell K, Lam-Damji S, Fehlings D. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Dev Med Child Neurol 2007; 49: 331 - 337.
152. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 2005; 47: 620 - 627.
153. Moore AP, Ade-Hall RA, Smith CT, et al. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. Neurology 2008; 71: 122 - 128.
154. Bjornson K, Hays R, Graubert C, et al. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. Pediatrics 2007; 120: 49 - 58.
155. Cony IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998; 18: 304 - 311.
156. Mall V, Heinen F, Siebel A, et al. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol 2006; 48: 10 - 13.
157. Reddihough DS, King JA, Coleman GJ, et al. Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol 2002; 44: 820 - 827.
158. Polak F, Morton R, Ward C, Wallace WA, Doderlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2002; 44: 551 - 555.
159. Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83: 481 - 487.
160. Steenbeek D, Meester-Delver A, Becher JG, Lankhorst GJ. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling. Clin Rehabil 2005; 19: 274 - 282.
161. Baker R, Jasinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002; 44: 666 - 675.
162. Kanovsky P, Bares M, Severa S, et al. Functional benefit of botulinum toxin (Dysport) in the treatment of dynamic equinus cerebral palsy spasticity: a prospective, multicenter, double-blind, placebo-controlled study. Ces A Slov Neurol Neurochir 2004; 67: 16 - 23.
163. Wenzel R, Jones D, Borrego JA. Comparing two botulinum toxin type A formulations using manufacturers' product summaries. J Clin Pharm Ther 2007; 32: 387 - 402.
164. Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Br J Dermatol 2003; 149: 1041 - 1045.
165. Simpson DM, Gracies JM, Graham HK, et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70: 1691 - 1698.
166. Tilton AH. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol 2004; 11: 58 - 65.
167. Mathew A, Mathew MC, Thomas M, Antonisamy B. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Pediatr 2005; 51: 109 - 113.
168. Engle HA. The effect of diazepam (Valium) in children with cerebral palsy: a double-blind study. Dev Med Child Neurol 1966; 8: 661 - 667.
169. Holt KS. The use of diazepam in childhood cerebral palsy. Report of a small study including electromyographic observations. Ann Phys Med 1964; suppl: 16 - 24.
170. Hiller CJ, Mason JL, Jr. Therapeutic test of diazepam (valium) in cerebral palsy. J S C Med Assoc 1966; 62: 306 - 309.
171. Joynt RL, Leonard JA, Jr. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Dev Med Child Neurol 1980; 22: 755 - 767.
172. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999; 10: 1 - 9.
173. Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83: 481 - 487.
174. Baker R, Jasinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002; 44: 666 - 675.
175. Koman LA, Mooney 3rd JF, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000; 20: 108 - 115.
176. Wissel J, Heinen F, Schenkel A, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 1999; 30: 120 - 124.
177. Polak F, Morton R, Ward C, Wallace WA, Doderlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2002; 44: 551 - 555.
178. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 2005; 47: 620 - 627.
179. Cony IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998; 18: 304 - 311.
180. Desloovere K, Molenaers G, Jonkers I, et al. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol 2001; 8 suppl 5: 75 - 87.
181. Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 1999; 35: 71 - 77.
182. Bottos M, Benedetti MG, Salucci P, Gasparroni V, Giannini S. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol 2003; 45: 758 - 762.
183. Kay RM, Rethlefsen SA, Fern-Buneo A, Wren TA, Skaggs DL. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am 2004; 86-A: 2377 - 2384.
184. Cony IS, Cosgrove AP, Duffy CM, Taylor TC, Graham HK. Botulinum toxin A in hamstring spasticity. Gait Posture 1999; 10: 206 - 210.
185. Thompson NS, Baker RJ, Cosgrove AP, Cony IS, Graham HK. Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait. Dev Med Child Neurol 1998; 40: 622 - 625.
186. Mall V, Heinen F, Siebel A, et al. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol 2006; 48: 10 - 13.
187. Barwood S, Baillieu C, Boyd R, et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000; 42: 116 - 121.
188. Cony IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997; 39: 185 - 193.
189. Fehlings D, Rang M, Glazier J, Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 2000; 137: 331 - 337.
190. Speth LA, Leffers P, Janssen-Potten YJ, Vies JS. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy. Dev Med Child Neurol 2005; 47: 468 - 473.
191. Russell DJ. Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. / DJ. Russell, LM. Avery, PL. Rosenbaum [et al.]. // Phys Ther. - 2000. - Sep; 80(9). - p. 873 - 885.
192. Шкала великих моторних функцій (Gross Motor Function Measure - GMFM) // Все про ДЦП. Інформація для пацієнтів, їх сімей та спеціалістів [Електронний ресурс]. - Режим доступу: http://www.dcp. com. ua/sites/default/files/GMFM-blank-ukr.pdf
193. Eliasson A.-C. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. / A.-C. Eliasson, L. Krumlinde [et al.]. // Developmental Medicine and child neurology. - 2006. - Jul; 48(7). - 549 - 554.
194. Gorter JW. Use of the GMFCS in infants with CP: the need for reclassification at age 2 years or older. / JW. Gorter, M. Ketelaar, P. Rosenbaum [et al.] // Dev Med Child Neurol. - 2009. - Jan; 51(1). p. 46 - 52.
195. Palisano R. Content validity of the expanded and revised Gross Motor Function Classification System. / R. Palisano, P. Rosenbaum [et al.] // Developmental Medicine & Child Neurology. - 2008. - 50 (10). p. 744 - 750.
196. Система класифікації великих моторних функцій (GMFCS) // Все про ДЦП. Інформація для пацієнтів, їх сімей та спеціалістів [Електронний ресурс]. - Режим доступу: http://www.dcp. com. ua/GMFCS
197. Новик А.А. Руководство по исследованию качества жизни в медицине. 2-е издание / Новик А.А., Ионова Т.И. - М.: ЗАО "ОЛМА Медиа Групп", 2007. - 320 с.
198. Fairclough D. Method of analysis for longitudinal studies of health-related quality of life // Quality of Life Assessment in Clinical Trials. - Oxford University Press: Oxford, New York, Tokyo. 1998. P. 227 - 247.
199. Clopton N. Interrater and intrarater reliability of the modified Ashworth scale in children with hypertonia./ N. Clopton, J. Dutton, T. Featherston [et al.] // Pediatr Phys Ther 2005; 17: 268 - 74.
200. Haugh AB. A systematic review of the Tardieu Scale for the measurement of spasticity./ AB. Haugh, AD. Pandyan, GR. Johnson. // Disabil Rehabil 2006; 28: 899 - 907.
201. BergM. Reliability of the pediatric evaluation of disability inventory (PEDI) / M. Berg, R. Jahnsen, K. Froslie, A. Hussain // Physical & Occupational Therapy in Pediatrics. - 2004. - V. 24, № 3. - P. 61 - 77.
202. Haley S, Coster, W, Ludlow L, Haltiwanger J, Andrellos J. Pediatric Evaluation of Disability Inventory (PEDI). Boston: Trustees of Boston Univeristy, 1998.
203. Ketelaar M. Effects of a functional therapy program on motor abilities of children with cerebral palsy / M. Ketelaar, A. Vermeer, H. Hart [et al.] // Phys Ther. - 2001. - V. 81, № 9. - P. 1534 - 1545.
204. Данилов О.А. Етапне гіпсування дітей з органічним ураженням нервової системи / О.А. Данилов, В.І. Машуренко, О.Г. Крамчанінова // Соціальна педіатрія. Збірник наукових праць. Випуск III. - К.: Інтермед, 2005. - С. 168 - 169.
205. Ненько А.М. Оригинальные методы хирургического лечения детей с церебральным параличом, разработанные в специализированном клиническом санатории / А.М. Ненько, А.В. Дерябин // Вестник физиотерапии и курортологии. - 2007. - № 2. - С. 54 - 56.
206. T. Pountney. Physiotherapy for children. // Elsevier, 2007, p. 97.
207. Мартинюк В.Ю. Дитячий церебральний параліч // Соціальна педіатрія та реабілітологія. - 2012. - № 1.
208. Класифікація уражень нервової системи у дітей та підлітків : метод. посібник / за ред. В.Ю. Мартинюка. - К.: Фенікс, 2001. - 190 с.
209. Aarts, P. B., Jongerius, P. H, Geerdink, Y. A., Van Limbeek, J., Geurts, A. C, Effectiveness of modified constraint-induced movement therapy in children with unilateral spastic cerebral palsy: A randomized controlled trial, Neurorehabilitation and Neural Repair, 24, 509 - 518, 2010.
210. Aarts, P. B., Jongerius, P. H, Geerdink, Y. A., Van Limbeek, J., Geurts, A. C, Modified Constraint-Induced Movement Therapy combined with Bimanual Training (mCIMT-BiT) in children with unilateral spastic cerebral palsy: how are improvements in arm-hand use established?, Research in Developmental Disabilities, 32, 271 - 279, 2011.
211. Abbott, R, Complications with selective posterior rhizotomy, Pediatric Neurosurgery, 18, 43 - 47, 1992.
212. Ackman, J. D., Russman, B. S., Thomas, S. S., Buckon, C. E., Sussman, M. D., Masso, P., Sanders, J., D'Astous, J., Aiona, M. D., Shriners Hospitals, B. T. X., Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy, Developmental Medicine and Child Neurology, 47, 620 - 627, 2005.
213. Awaad, Y., Tayem, H., Munoz, S., Ham, S., Michon, A. M., Awaad, R., Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy, Journal of Child Neurology, 18, 26 - 34, 2003.
214. Boyd, R. N, The central and peripheral effects of botulinum toxin A in children with cerebral palsy, Doctor of Philosophy thesis, Victoria: Schools of Human Biosciences and Physiotherapy, Faculty of Health Sciences, La Trobe University, 2004.
215. Buckon, C. E., Thomas, S. S., Jakobson-Huston, S., Sussman, M., Aiona, M., Comparison of three anklefoot orthosis configurations for children with spastic hemiplegia, Developmental Medicine and Child Neurology, 43, 371 - 378, 2001.
216. Buckon, C. E., Thomas, S. S., Jakobson-Huston, S., Moor, M., Sussman, M., Aiona, M., Comparison of three ankle-foot orthosis configurations for children with spastic diplegia, Developmental Medicine and Child Neurology, 46, 590 - 598, 2004.
217. Buckon, C. E., Thomas, S. S., Piatt, J. H., Jr., Aiona, M. D., Sussman, M. D., Selective dorsal rhizotomy versus orthopedic surgery: a multidimensional assessment of outcome efficacy, Archives of Physical Medicine and Rehabilitation, 85, 457 - 465, 2004.
218. Carlson, W. E., Vaughan, C. L., Damiano, D. L., Abel, M. F., Orthotic management of gait in spastic diplegia, American Journal of Physical Medicine and Rehabilitation, 76, 219 - 225, 1997.
219. Curtis L. Unit costs of health & social care, Personal Social Services Research Unit (PSSRU), University of Kent, 2011 References 28.
220. Denhoff, E., Feldman, S., Smith, M. G., Litchman, H., Holden, W., Treatment of spastic cerebral-palsied children with sodium dantrolene, Developmental Medicine and Child Neurology, 17, 736 - 742, 1975.
221. Department of Health, The National Service Framework for long term conditions, March 2005, Annex (Based on figures in The Neurological Alliance, Neuro Numbers: A Brief Review of the Numbers of People in the UK with a Neurological Condition, April 2003.
222. Department of Health, Payment by Results Guidance 2011 - 12, Department of Health, 2011.
223. Dodd, K. J., Taylor, N. F., Graham, H. K., A randomized clinical trial of strength training in young people with cerebral palsy, Developmental Medicine and Child Neurology, 45, 652 - 657, 2003.
224. Dodd, K. J., Taylor, N. F., Graham, H. K, Strength training can have unexpected effects on the selfconcept of children with cerebral palsy, Pediatric Physical Therapy, 16, 99 - 105, 2004.
225. Edwards, K, Economic analysis of selective dorsal rhizotomy in the UK, unpublished dissertation 2010.
226. Elliott, C. M., Reid, S. L., Alderon, J. A., Elliott, B. C., Lycra arm splints in conjunction with goal-directed training can improve movement in children with cerebral palsy, Neurorehabilitation, 28, 47 - 54, 2011.
227. Fehlings, D., Rang, M., Glazier, J., Steele, C., An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy, Journal of Pediatrics, 137, 331 - 337, 2000.
228. Fowler, E. G., Knutson, L. M., Demuth, S. K, Siebert, K. L, Simms, V. D., Sugi, M. H, Souza, R. B., Karim, R, Azen, S. P., Physical Therapy Clinical Research Network (PTClinResNet), Pediatric endurance and limb strengthening (PEDALS) for children with cerebral palsy using stationary cycling: a randomized controlled trial, Physical Therapy, 90, 367 - 381, 2010.
229. Gilmartin, R., Bruce, D., Storrs, B. B., Abbott, R., Krach, L., Ward, J., Bloom, K., Brooks, W. H., Johnson, D. L., Madsen. J. R., McLaughlin, J. F., Nadell, J., Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial, Journal of Child Neurology, 15, 71 - 77, 2000.
230. Gorton, G. E., III, Abel, M. F., Oeffinger, D. J., Bagley, A., Rogers, S. P., Damiano, D., Romness, M., Tylkowski, C., A prospective cohort study of the effects of lower extremity orthopaedic surgery on outcome measures in ambulatory children with cerebral palsy, Journal of Pediatric Orthopedics, 29, 903 - 909, 2009.
231. Greave, S. M., The effect of botulinum toxin A injections on occupational therapy outcomes for children with spastic hemiplegia, Master of Occupational Therapy thesis, Victoria: School of Occupational Therapy, Faculty of Health Sciences, La Trobe University, 2004.
232. Haslam, R. H., Walcher, J. R., Lietman, P. S., Kallman, C. H., Mellits, E. D., Dantrolene sodium in children with spasticity, Archives of Physical Medicine and Rehabilitation, Arch Phys Med Rehabil, 55, 384 - 388, 1974.
233. Spasticity in children and young people with non-progressive brain disorders, 286.
234. Hoare, B. J., Wallen, M. A., Imms, C., Villanueva, E., Rawicki, H. B., Carey, L., Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE), Cochrane database of systematic reviews (Online), #2010. Date of Publication, CD003469-, 2010.
235. Hoving, M. A., van Raak, E. P., Spincemaille, G. H., Palmans, L. J., Sleypen, F. A., Vles, J. S., Dutch Study Group on Child Spasticity., Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study, Developmental Medicine and Child Neurology, 49, 654 - 659, 2007.
236. Hoving, M. A., van Raak, E. P., Spincemaille, G. H., Palmans, L. J., Becher, J. G., Vles, J. S., Dutch Study Group on Child Spasticity., Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial, European Journal of Paediatric Neurology, 13, 240 - 246, 2009.
237. Hoving, M. A., van Raak, E. P., Spincemaille, G. H., van Kranen-Mastenbroek, V. H., van, Kleef M., Gorter, J. W., Vles, J. S., Dutch Study Group on Child Spasticity., Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy, European Journal of Paediatric Neurology, 13, 247 - 256, 2009.
238. Jacobsson B, Hagberg G., Antenatal risk factors for cerebral palsy, Best Practice & Research Clinical Obstetrics & Gynaecology, 18, 425 - 36, 2004.
239. Jevsevar D. S. and Karlin L. I., The relationship between preoperative nutritional status and complications after an operation for scoliosis in patients who have cerebral palsy, Journal of Bone and Joint Surgery - American Volume, 75, 880 - 4, 1993.
240. Joynt, R. L., Leonard, J. A., Jr., Dantrolene sodium suspension in treatment of spastic cerebral palsy, Developmental Medicine and Child Neurology, 22, 755 - 767, 1980.
241. Kanovsky, P., Bares, M., Severa, S., Richardson, A., Dysport Paediatric Limb Spasticity Study Group., Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy, Developmental Medicine and Child Neurology, 51, 436 - 445, 2009.
242. Katz-Leurer, M., Rotem, H., Keren, O., Meyer, S., The effects of a 'home-based' task-oriented exercise programme on motor and balance performance in children with spastic cerebral palsy and severe traumatic brain injury, Clinical Rehabilitation, 23, 714 - 724, 2009.
243. Kay, R. M., Rethlefsen, S. A., Fern-Buneo, A., Wren, T. A. L., Skaggs, D. L., Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy, Journal of Bone and Joint Surgery - Series A, 86, 2377-Series, 2004.
244. Kim, D. S., Choi, J. U., Yang, K. H., Park, C. L., Selective posterior rhizotomy in children with cerebral palsy: a 10-year experience, Childs Nervous System, 17, 556 - 562, 2001 References 287.
245. Krach, L. E, Kriel, R. L., Gilmartin, R. C., Swift, D. M., Storrs, B. B., Abbott, R., Ward, J. D., Bloom, K. K., Brooks, W. H., Madsen, J. R, McLaughlin, J. F., Nadell, J. M., Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion, Pediatric Neurology, 30, 163 - 168, 2004.
246. Kwon, J. Y., Hwang, J. H, Kim, J. S., Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report, American Journal of Physical Medicine and Rehabilitation, 89, 279 - 286, 2010.
247. Law, M. C., Darrah, J., Pollock, N., Wilson, B., Russell, D. J., Walter, S. D., Rosenbaum, P., Galuppi, B., Focus on function: a cluster, randomized controlled trial comparing child-versus context-focused intervention for young children with cerebral palsy. Developmental Medicine & Child Neurology, 53, 621 - 629, 2011.
248. Lee, J. H, Sung, J. Y., Yoo, J. Y., Therapeutic effects of strengthening exercise on gait function of cerebral palsy, Disability and Rehabilitation, 30, 1439 - 1444, 2008.
249. Liao, H. F., Liu, Y. C, Liu, W. Y., Lin, Y. T., Effectiveness of loaded sit-to-stand resistance exercise for children with mild spastic diplegia: a randomized clinical trial, Archives of Physical Medicine and Rehabilitation, 88, 25 - 31, 2007.
250. Lonstein J. E., Koop S. E., Novachek T. F. et ah, Results and complications following spinal fusion for neuromuscular scoliosis in cerebral palsy and static encephalopathy using luque galveston instrumentation: experience in 93 patients, Spine, June 13 ePub ahead of print, 2011.
251. Lowe, K., Novak, J., Cusick, A., Low-dose / high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy, Developmental Medicine and Child Neurology, 48, 170 - 175, 2006.
252. Mathew, A., Mathew, M. C, Bedtime diazepam enhances well-being in children with spastic cerebral palsy, Pediatric Rehabilitation, 8, 63 - 66, 2005.
253. Mathew, A., Mathew, M. C, Thomas, M., Antonisamy, B., The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy, Journal of Tropical Pediatrics, 51, 109 - 113, 2005.
254. McKinlay J., Hyde, E., Gordon, N., Baclofen: A team approach to drug evaluation of spasticity in childhood, Scottish Medical Journal, Scott. Med. J., 25, S-S, 1980.
255. McLaughlin, J. F., Bjornson, K. F., Astley, S. J., Graubert, C., Hays, R. M., Roberts, T. S., Price, R., Temkin, N., Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. [62 refs], Developmental Medicine and Child Neurology, 40, 220 - 232, 1998.
256. McNee, A. E., Will, E., Lin, J. P., Eve, L. C, Gough, M., Morrissey, M. C, Shortland, A. P., The effect of serial casting on gait in children with cerebral palsy: preliminary results from a cross-over trial, Gait and Posture, 25, 463 - 468, 2007 Spasticity in children and young people with non-progressive brain disorders 288.
257. McNerney N. P., Mubarak S. J., and Wenger D. R., One-stage correction of the dysplastic hip in cerebral palsy with the San Diego acetabuloplasty: results and complications in 104 hips, Journal of Pediatric Orthopedics, 20, 93 - 103, 2000.
258. Medical Services Advisory Committee, Selective Dorsal Rhizotomy: Assessment for Nationally Funded Centre Status - A report by the Medical Services Advisory Committee to the Australian Health Ministers' Advisory Council, 2006.
259. Milla, P. J., Jackson, A. D., A controlled trial of baclofen in children with cerebral palsy, Journal of International Medical Research, 5, 398 - 404, 1977.
260. Molenaers, G., Desloovere, K., De, Cat J., Jonkers, J., De, Borre L., Pauwels, P., Nijs, J., Fabry, G., De, Cock P., Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences, European Journal of Neurology, 8 Suppl 5, 88 - 97, 2001.
261. Motta, F., Stignani, C., Antonello, C. E., Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales, Journal of Pediatric Orthopedics, 28, 213 - 217, 2008.
262. Newman, C. J., Kennedy, A., Walsh, M., O'Brien, T., Lynch, B., Hensey, O., A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus, Journal of Pediatric Orthopedics, 27, 882 - 885, 2007.
263. NHS, NHS Classification Service Coding Clinic Volume 3, National Health Service, 200.
264. Novak, J., Cusick, A., Lannin, N., Occupational therapy home programs for cerebral palsy: double-blind, randomized, controlled trial, Pediatrics, 124, e606 - e614, 2009.
265. Olesch, C. A., Greaves, S., Imms, C., Reid, S. M., Graham, H. K., Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial, Developmental Medicine and Child Neurology, 52, 79 - 86, 2010.
266. Radtka, S. A., Skinner, S. R, Johanson, M. E., A comparison of gait with solid and hinged ankle-foot orthoses in children with spastic diplegic cerebral palsy, Gait and Posture, 21, 303 - 310, 2005.
267. Ramstad, K., Jahnsen, R., Lofterod, B., Skjeldal, O. H., Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?, Acta Paediatrica, 99, 1661 - 1665, 2010.
268. Reddihough, D. S., King, J. A., Coleman, G. J., Fosang, A., McCoy, A. T., Thomason, P., Graham, H. K., Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy, Developmental Medicine and Child Neurology, 44, 820 - 827, 2002.
269. Rethlefsen, S., Kay, R., Dennis, S., Forstein, M., Tolo, V., The effects of fixed and articulated ankle-foot orthoses on gait patterns in subjects with cerebral palsy, Journal of Pediatric Orthopaedics, 19, 470 - 474, 1999 References 289.
270. Rice, J., Waugh, M. C, Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy, Journal of Child Neurology, 24, 176 - 182, 2009.
271. Russo, R. N, Crotty, M., Miller, M. D., Murchland, S., Flett, P., Haan, E., Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial, Pediatrics, 119, ell49 - ell58, 2007.
272. Sakzewski, L., Ziviani, J., Abbott, D. F., Macdonell, R. A. L., Jackson, G. D., Boyd, R. N, Randomized trial of constraint-induced movement therapy and bimanual training on activity outcomes for children with congenital hemiplegia, Developmental Medicine & Child Neurology, 53, 313 - 320, 2011.
273. Sampson FC, et al. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 96: 1052 - 1057, 2002.
274. Sanger, T. D., Delgado, M. R., Gaebler-Spira, D., Hallett, M., Mink, J. W., Task Force on Childhood Motor Disorders, Classification and definition of disorders causing hypertonia in childhood, Pediatrics, 111, e89 - e97, 2003.
275. Scheinberg, A., Hall, K., Lam, L. T., O'Flaherty, S., Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study, Journal of Paediatrics and Child Health, 42, 715 - 720, 2006.
276. Senaran, H., Shah, S. A., Presedo, A., Dabney, K. W., Glutting, J. W., Miller, F., The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy, Spine, 32, 2348 - 2354, 2007.
277. Shilt, J. S., Lai, L. P., Cabrera, M. N, Frino, J., Smith, B. P., The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy, Journal of Pediatric Orthopedics, 28, 684 - 687, 2008.
278. Sienko, Thomas S., Buckon, C. E., Jakobson-Huston, S., Sussman, M. D., Aiona, M. D., Stair locomotion in children with spastic hemiplegia: the impact of three different ankle foot orthosis (AFOs) configurations, Gait and Posture, 16, 180 - 187, 2002.
279. Speth, L. A. W. M., Leffers, P., Janssen-Potten, Y. J. M., Vles, J. S. H., Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: A randomized trial in children receiving intensive therapy, Developmental Medicine and Child Neurology, 47, 468 - 473, 2005.
280. Sponseller P. D., LaPorte D. M., Hungerford M. W. et al., Deep wound infections after neuromuscular scoliosis surgery: a multicenter study of risk factors and treatment outcomes, Spine, 25, 2461 - 6, 2000.
281. Steinbok, P., Reiner, A. M., Beauchamp, R., Armstrong, R. W., Cochrane, D. D., Kestle, J., A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. [Erratum appears in Dev Med Child Neurol 1997 Nov; 39(11): inside back cov], Developmental Medicine and Child Neurology, 39, 178 - 184, 1997.
282. Surman G, HemmingK et al Children with cerebral palsy: severity and trends over time. Paediatr Perinat Epidemiol, Nov; 23(6): 513 - 521, 2009 Spasticity in children and young people with non-progressive brain disorders 290.
283. Szoke G., Lipton G., Miller F. et al., Wound infection after spinal fusion in children with cerebral palsy, Journal of Pediatric Orthopedics, 18, 727 - 33, 1998.
284. Thomason, P., Baker, R., Dodd, K., Taylor, N., Selber, P., Wolfe, R., Graham, H. K., Single-event multilevel surgery in children with spastic diplegia: a pilot randomized controlled trial, Journal of Bone and Joint Surgery - American Volume, 93, 451 - 460, 2011.
285. Tsirikos A. I., Lipton G., Chang W. N. et al., Surgical correction of scoliosis in pediatric patients with cerebral palsy using the unit rod instrumentation, Spine, 33, 1133 - 40, 2008.
286. Ubhi, T., Bhakta, B. B., Ives, H. L., Allgar, V., Roussounis, S. H., Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy, Archives of Disease in Childhood, 83, 481 - 487, 2000.
287. Unger, M., Faure, M., Frieg, A., Strength training in adolescent learners with cerebral palsy: a randomized controlled trial, Clinical Rehabilitation, 20, 469 - 477, 2006.
288. Wallen, M., O'Flaherty, S. J., Waugh, M. C, Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial, Archives of Physical Medicine and Rehabilitation, 88, 1 - 10, 2007.
289. Wright, F. V., Sheil, E. M., Drake, J. M., Wedge, J. H., Naumann, S., Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled tria, Developmental Medicine and Child Neurology, 40, 239 - 247, 1998.
290. Xu, K., Yan, T., Mai, J., A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy, Clinical Rehabilitation, 23, 800 - 811, 2009.
291. Yang, E. J., Rha, D., Kim, H. W., Park, E. S., Comparison of Botulinum Toxin Type A Injection and Soft-Tissue Surgery to Treat Hip Subluxation in Children With Cerebral Palsy, Archives of Physical Medicine and Rehabilitation, 89, 2108 - 2113, 2008.